LY573636-sodium

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for LY573636-sodium, covering 2018-05-02 to 2018-10-19. Get the full timeline:

Most recent: Clinical Trial Update: Study of LY573636-Sodium in Patients With Metastatic Non-Small Cell Lung Cancer [Phase 2]